Soteropoulos Paula

CIK 00016924444 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001692444

Recent Transactions

50 trades

Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-31−599→ 599 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$8.44/sh+599→ 599 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$80.11/sh−599→ 0 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-24$8.44/sh+27,594→ 27,594 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-24$78.05/sh−27,594→ 0 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-24−27,594→ 1,198 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-05-22+12,500→ 12,500 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2025-05-13+28,500→ 28,500 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2024-06-13$5.14/sh−2,220→ 20,203 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2024-05-23+11,000→ 11,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2024-05-15+16,500→ 16,500 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2023-09-11+6,500→ 6,500 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-06-16$18.99/sh−2,275→ 22,423 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2023-06-13+17,060→ 17,060 total
Award
uniQure N.V.$QURE
Ordinary Shares
2023-06-13+8,700→ 24,698 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2023-05-17+15,490→ 15,490 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-02-27$19.97/sh−384→ 15,998 total
Exercise/Conversion
uniQure N.V.$QURE
Stock Option (Right to Buy)
2023-01-18−6,000→ 2,000 total
Exercise/Conversion
uniQure N.V.$QURE
Ordinary Shares
2023-01-18$5.37/sh+6,000→ 22,382 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-01-18$22.59/sh−6,000→ 16,382 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2022-12-14$23.43/sh−3,800→ 16,382 total
Exercise/Conversion
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-12-14−3,800→ 0 total
Exercise/Conversion
uniQure N.V.$QURE
Ordinary Shares
2022-12-14+3,800→ 20,182 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2022-12-13$23.45/sh−3,000→ 16,382 total
Exercise/Conversion
uniQure N.V.$QURE
Ordinary Shares
2022-12-13$5.37/sh+3,000→ 19,382 total
Exercise/Conversion
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-12-13−3,000→ 8,000 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2022-11-29$25.38/sh−6,200→ 16,382 total
Exercise/Conversion
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-11-29−6,200→ 3,800 total
Exercise/Conversion
uniQure N.V.$QURE
Ordinary Shares
2022-11-29+6,200→ 22,582 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-06-15+17,810→ 17,810 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-06-15+9,080→ 16,382 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2022-05-24+13,440→ 13,440 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2022-02-28$16.87/sh−596→ 7,302 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-02-24+2,645→ 2,645 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-02-24+1,534→ 7,898 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2022-01-03+5,369→ 5,369 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2021-03-02$37.60/sh−504→ 6,364 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2021-02-25+4,107→ 4,107 total
Award
uniQure N.V.$QURE
Ordinary Shares
2021-02-25+2,382→ 6,868 total
Award
uniQure N.V.$QURE
Ordinary Shares
2020-02-27+2,063→ 4,486 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2020-02-27+3,620→ 3,620 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-02-05$61.53/sh−822→ 2,423 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-02-05$60.58/sh−1,300→ 3,245 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-28$62.19/sh−807→ 4,545 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-07$72.18/sh−3,000→ 5,352 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2019-12-13$70.50/sh−2,000→ 8,352 total
Exercise/Conversion
uniQure N.V.$QURE
Ordinary Shares
2019-12-13$5.37/sh+2,000→ 10,352 total
Exercise/Conversion
uniQure N.V.$QURE
Stock Option (Right to Buy)
2019-12-13+2,000→ 9,000 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2019-12-09$67.50/sh−2,500→ 8,352 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2019-12-06$64.39/sh−7,382→ 10,852 total

Companies

Recent Filings

Address

C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR

NEW YORK, NY, 10036

View on SEC.gov